Topcon Medical Systems
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Topcon Medical Systems sits in the top decile of US sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count).
Topcon Medical Systems: 24 sponsored US clinical trials, none currently recruiting.
Topcon Medical Systems sponsors 24 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 21 completed. 3 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Ocular Images, with 1 trials.
Top-decile sponsor footprint
Topcon Medical Systems ranks in the top decile of sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
21 of 24 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
24 total, page 1 of 1
Comparative Study of the Topcon Tonometers CT-800 and TRK-2P and the Haag-Streit Goldmann Manual Tonometer and Topcon SP-1P
NCT03439774
Triton Fundus Autofluorescence and Fluorescein Angiography
NCT03107104
Triton Agreement and Precision Study
NCT03080714
TopQ Cutoff Threshold Validation Study for DRI OCT Triton Plus
NCT03022383
Evaluation of the Signal to Noise Ratio at Various Retinal Layers
NCT02982174
Slit Lamp Model SL-D-301 and DC-4 Digital Camera Attachment
NCT02851147
Topcon 3D OCT-1 Maestro Reference Database Study II
NCT02447120
TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro
NCT02447133
Maestro Agreement and Precision Study II
NCT02376868
Second Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements
NCT02427256
Slit Lamp and Digital Camera Attachment
NCT02444039
Clinical Study of the Optic Disc Parameters
NCT02277119
Retinal Fundus Camera Evaluation
NCT02293174
Comparative Study of Non-contact Tonometers for Intraocular Pressure and Corneal Cell Thickness Measurements
NCT02138279
Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements
NCT02138266
TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000
NCT02203981
OCT Agreement and Precision Study
NCT02045823
OCT Reference Database
NCT01986478
Clinical Validation of New OCT System
NCT01809704
TopQ Cut-Off Determination Study
NCT01824784
Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia
NCT01398852
Safety Study of the VEGA UV-A System to Treat Ectasia
NCT01398839
Safety Study of the VEGA UV-A System to Treat Keratoconus
NCT01190306
Topcon 3D OCT-1000 Optical Coherence Tomography System
NCT00792259
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 3 |
Therapeutic Areas
How the Topcon Medical Systems archive is shaped
24 indexed studies, none listed as recruiting (0% open); 21 completed (88%).
Phase mix: 3 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Ocular Images (1 trial), 5 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Topcon Medical Systems: archived-pipeline peers nationwide
Peers matched on 24 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Topcon Medical Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 24 archived trials
- Acrotech Biopharma · 24 trials · 8% recruiting
- Agenus · 24 trials · 0% recruiting
- Akebia Therapeutics · 24 trials · 4% recruiting
- Blueprint Medicines Corporation · 24 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Topcon Medical Systems page
24 registered trials is a research-attention snapshot, not an endorsement of Topcon Medical Systems or any single study.
- None of Topcon Medical Systems's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Ocular Images is the condition Topcon Medical Systems studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Ocular Images trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Topcon Medical Systems pipeline card: 24 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.